HUP0102607A3 - Imidazole derivatives with sulfonyl biphenyl methyl pharmautical compositions containing them and their use - Google Patents
Imidazole derivatives with sulfonyl biphenyl methyl pharmautical compositions containing them and their useInfo
- Publication number
- HUP0102607A3 HUP0102607A3 HU0102607A HUP0102607A HUP0102607A3 HU P0102607 A3 HUP0102607 A3 HU P0102607A3 HU 0102607 A HU0102607 A HU 0102607A HU P0102607 A HUP0102607 A HU P0102607A HU P0102607 A3 HUP0102607 A3 HU P0102607A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmautical
- compositions containing
- imidazole derivatives
- biphenyl methyl
- sulfonyl biphenyl
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19832428A DE19832428A1 (de) | 1998-07-18 | 1998-07-18 | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PCT/EP1999/004887 WO2000003996A1 (de) | 1998-07-18 | 1999-07-10 | Imidazolderivate mit biphenylsulfonylsubstitution, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102607A2 HUP0102607A2 (hu) | 2002-03-28 |
| HUP0102607A3 true HUP0102607A3 (en) | 2002-05-28 |
Family
ID=7874574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102607A HUP0102607A3 (en) | 1998-07-18 | 1999-07-10 | Imidazole derivatives with sulfonyl biphenyl methyl pharmautical compositions containing them and their use |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6369236B1 (hu) |
| EP (1) | EP1097141B1 (hu) |
| JP (1) | JP4567885B2 (hu) |
| KR (1) | KR20010071957A (hu) |
| CN (1) | CN1211370C (hu) |
| AR (1) | AR019405A1 (hu) |
| AT (1) | ATE362920T1 (hu) |
| AU (1) | AU764438B2 (hu) |
| BR (1) | BR9912241A (hu) |
| CA (1) | CA2338059A1 (hu) |
| DE (2) | DE19832428A1 (hu) |
| HK (1) | HK1038743A1 (hu) |
| HU (1) | HUP0102607A3 (hu) |
| ID (1) | ID27774A (hu) |
| PL (1) | PL345585A1 (hu) |
| RU (1) | RU2246488C2 (hu) |
| TR (1) | TR200100134T2 (hu) |
| WO (1) | WO2000003996A1 (hu) |
| ZA (1) | ZA200100278B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
| US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
| BRPI0814403A2 (pt) | 2007-07-02 | 2015-01-27 | Hoffmann La Roche | Devirados de imidazol como antagonistas de receptor ccr2 |
| EP2321281A4 (en) | 2008-09-02 | 2011-09-28 | Elder Pharmaceuticals Ltd | INFLAMMATORY CONNECTIONS |
| KR101044953B1 (ko) * | 2009-01-07 | 2011-06-29 | (주) 인우 코퍼레이션 | 이중분사노즐을 이용한 악취제거 시스템 |
| WO2015198945A1 (ja) * | 2014-06-23 | 2015-12-30 | 日産化学工業株式会社 | スルホニル結合を有するシラン化合物の製造方法 |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| WO1992020662A1 (en) * | 1991-05-10 | 1992-11-26 | Merck & Co., Inc. | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
| TW215434B (hu) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
| US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| FR2711367B1 (fr) | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2711368B1 (fr) * | 1993-09-16 | 1996-01-05 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2716882B1 (fr) | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
| FR2716883B1 (fr) | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0855392A3 (de) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1998
- 1998-07-18 DE DE19832428A patent/DE19832428A1/de not_active Withdrawn
-
1999
- 1999-07-10 CA CA002338059A patent/CA2338059A1/en not_active Abandoned
- 1999-07-10 AT AT99938222T patent/ATE362920T1/de not_active IP Right Cessation
- 1999-07-10 WO PCT/EP1999/004887 patent/WO2000003996A1/de not_active Application Discontinuation
- 1999-07-10 ID IDW20010129A patent/ID27774A/id unknown
- 1999-07-10 DE DE59914347T patent/DE59914347D1/de not_active Expired - Lifetime
- 1999-07-10 BR BR9912241-3A patent/BR9912241A/pt not_active Application Discontinuation
- 1999-07-10 KR KR1020017000752A patent/KR20010071957A/ko not_active Application Discontinuation
- 1999-07-10 PL PL99345585A patent/PL345585A1/xx not_active Application Discontinuation
- 1999-07-10 RU RU2001104449/04A patent/RU2246488C2/ru not_active IP Right Cessation
- 1999-07-10 JP JP2000560103A patent/JP4567885B2/ja not_active Expired - Fee Related
- 1999-07-10 TR TR2001/00134T patent/TR200100134T2/xx unknown
- 1999-07-10 HU HU0102607A patent/HUP0102607A3/hu unknown
- 1999-07-10 AU AU52807/99A patent/AU764438B2/en not_active Ceased
- 1999-07-10 EP EP99938222A patent/EP1097141B1/de not_active Expired - Lifetime
- 1999-07-10 CN CNB998087416A patent/CN1211370C/zh not_active Expired - Fee Related
- 1999-07-10 US US09/743,957 patent/US6369236B1/en not_active Expired - Lifetime
- 1999-07-15 AR ARP990103486A patent/AR019405A1/es not_active Application Discontinuation
-
2001
- 2001-01-10 ZA ZA200100278A patent/ZA200100278B/en unknown
- 2001-12-28 HK HK01109164A patent/HK1038743A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE362920T1 (de) | 2007-06-15 |
| CN1309645A (zh) | 2001-08-22 |
| HUP0102607A2 (hu) | 2002-03-28 |
| AU5280799A (en) | 2000-02-07 |
| KR20010071957A (ko) | 2001-07-31 |
| EP1097141B1 (de) | 2007-05-23 |
| TR200100134T2 (tr) | 2001-07-23 |
| US6369236B1 (en) | 2002-04-09 |
| ZA200100278B (en) | 2001-08-06 |
| JP2002520399A (ja) | 2002-07-09 |
| WO2000003996A1 (de) | 2000-01-27 |
| RU2246488C2 (ru) | 2005-02-20 |
| HK1038743A1 (en) | 2002-03-28 |
| JP4567885B2 (ja) | 2010-10-20 |
| CA2338059A1 (en) | 2000-01-27 |
| DE19832428A1 (de) | 2000-01-20 |
| DE59914347D1 (de) | 2007-07-05 |
| ID27774A (id) | 2001-04-26 |
| CN1211370C (zh) | 2005-07-20 |
| AU764438B2 (en) | 2003-08-21 |
| PL345585A1 (en) | 2001-12-17 |
| AR019405A1 (es) | 2002-02-20 |
| EP1097141A1 (de) | 2001-05-09 |
| BR9912241A (pt) | 2001-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001154A3 (en) | 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same | |
| AU2911399A (en) | Natural substance based agent | |
| EP1016400A4 (en) | COMPOSITION FOR EXTERNAL USE | |
| IL125179A0 (en) | New scleroglucans and cosmetic compositions containing the new compounds | |
| HK1031338A1 (en) | Liquid composition with enhanced low temperature stability | |
| GB2334718B (en) | Phenylacetylene compound and liquid crystal composition comprising the same | |
| HUP0100870A3 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
| HUP9801167A3 (en) | Triaromatic compounds, compositions containing the same and use thereof | |
| GB9813271D0 (en) | Composition and use | |
| PL347357A1 (en) | Novel composition and use | |
| EP0965321A4 (en) | COMPOSITION FOR EXTERNAL USE | |
| HUP0103636A3 (en) | 2-methyl-thieno-benzodiazepine formulation and its use | |
| GB9817354D0 (en) | Liquid formulation | |
| HUP0102607A3 (en) | Imidazole derivatives with sulfonyl biphenyl methyl pharmautical compositions containing them and their use | |
| GB9811168D0 (en) | Direct hair-colouring compositions and the use thereof | |
| GB9810529D0 (en) | Intumescent composition | |
| AU5338699A (en) | Imidazoles and related compounds as alpha1a agonists | |
| HK1019456A1 (en) | Polyethylene composition | |
| GB9803232D0 (en) | Compound composition and use | |
| HUP0103184A3 (en) | Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them | |
| AU2183899A (en) | Isoflavane derivatives and immunopotentiating compositions containing the same | |
| GB9810180D0 (en) | Novel formulation | |
| PL345768A1 (en) | Liquid formulation | |
| IL131158A0 (en) | 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists | |
| AU3171099A (en) | 1-heteroindene derivatives and medicinal composition containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |